India’s chemical and pharmaceutical industry is witnessing significant global expansion, emerging as a leading destination for Contract Development and Manufacturing Organisation (CDMO) services, Active Pharmaceutical Ingredients (APIs), fine chemicals, agrochemicals, and specialty chemicals. A recent Nuvama report highlights that government incentives, lower operational costs, and shifting global trends are fueling India's rise while Europe faces a decline in its chemical and pharmaceutical sectors.

India’s Growing Pharmaceutical and Chemical Industry

With rising energy and labor costs in Europe, multinational corporations (MNCs) are increasingly outsourcing production to India and China. This shift is reshaping the global market, making India a more attractive hub for pharmaceutical and chemical manufacturing.

The report notes that India is excelling in the production of low-cost generic APIs, an area where Europe is losing its competitive edge. Although European companies remain dominant in high-value CDMO services, biologics, oncology APIs, and advanced drug formulations, their share in the global chemical sales market has dropped from 23% in 2008 to just 13% in 2023 due to major plant closures and shifting market trends.

India, on the other hand, continues to scale up its pharmaceutical research industry, particularly in small-molecule drug development and specialty chemical production. The government's support in the form of incentives and regulatory reforms has further accelerated India’s dominance in pharmaceutical and chemical manufacturing.

Factors Driving India’s Market Growth

Several key factors contribute to India’s rise in the global chemical and pharmaceutical industries:

• Lower operational and production costs make India a preferred manufacturing hub.
• Government incentives and policy support boost domestic production and exports.
• Increasing foreign direct investment (FDI) encourages global partnerships and joint ventures.
• Advanced R&D facilities strengthen India’s pharmaceutical innovation.
• Growing demand for specialty chemicals and agrochemicals fuels industry expansion.

Europe’s Declining Market Share and Industry Shifts

While Europe remains a stronghold in high-value pharmaceutical manufacturing, its declining cost competitiveness has led to major shifts in production strategies.

• Many European plants are shutting down due to rising operational costs and stringent environmental regulations.
• India and China are becoming the preferred destinations for low-cost pharmaceutical and chemical production.
• Europe continues to lead in advanced drug formulations and specialty biologics but is losing ground in API and generic drug production.

India’s Future in Global Chemical and Pharmaceutical Markets

With aggressive expansion, investment in R&D, and government support, India is set to become a global leader in the chemical and pharmaceutical industries. The country's agrochemical exports are witnessing strong growth, further solidifying its position as a major chemical manufacturing hub.

The Nuvama report underscores how India’s growing presence in the chemical and pharmaceutical markets is transforming global supply chains. As Europe loses market share, India’s rapid industrial advancements and favorable regulatory environment ensure that it remains a key player in the industry’s future.

The Upcoming IPOs in this week and coming weeks are Balaji Phosphates.

The Current active IPO are Shreenath Paper, Nukleus Office, Beezaasan Explotech.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.

Join our Finance Saathi Telegram Channel for Regular Share Market, News & IPO Update.